The DOI matches its Crossref record; 284 of the 286 references it cites were found in a registry or an index.
Progress in brain targeting drug delivery system by nasal route
Abstract
The blood-brain barrier (BBB) restricts the transport of potential therapeutic moieties to the brain. Direct targeting the brain via olfactory and trigeminal neural pathways by passing the BBB has gained an important consideration for delivery of wide range of therapeutics to brain. Intranasal route of transportation directly delivers the drugs to brain without systemic absorption, thus avoiding the side effects and enhancing the efficacy of neurotherapeutics. Over the last several decades, different drug delivery systems (DDSs) have been studied for targeting the brain by the nasal route. Novel DDSs such as nanoparticles (NPs), liposomes and polymeric micelles have gained potential as useful tools for targeting the brain without toxicity in nasal mucosa and central nervous system (CNS). Complex geometry of the nasal cavity presented a big challenge to effective delivery of drugs beyond the nasal valve. Recently, pharmaceutical firms utilized latest and emerging nasal drug delivery technologies to overcome these barriers. This review aims to describe the latest development of brain targeted DDSs via nasal administration.Chemical compounds studied in this article Carbopol 934p (PubChem CID: 6581) Carboxy methylcellulose (PubChem CID: 24748) Penetratin (PubChem CID: 101111470) Poly lactic-co-glycolic acid (PubChem CID: 23111554) Tween 80 (PubChem CID: 5284448).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most investigated administration route for micelles is the intravenous (i.v.) injection/infusion (mainly exploited for chemotherapy) [18,[47][48][49], but very interesting results in terms of improved drug bioavailability have also been reported following oral [31,50] and topical (ocular, nasal, buccal) [26,36,51,52] administration.”
From Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions (2021) · cites this paper as [50]
Citations
Cites
1 retracted
Pal, A., Gupta, S., Jaiswal, A. K., Dube, A., & Vyas, S. P. (2011) · Journal of Liposome Research · doi:10.3109/08982104.2011.592495 · Cited by 39
RetractedRecent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816 · cited 2×
“Most of the research over last several years was focused on polymeric NPs based on poly (lactic acid) (PLA), poly (D.L-lactide-co-glycolide) (PLGA) and poly (glycolic acid) (PGA) for brain targeted delivery [85].”
BackgroundDaneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437
Rejman, J., Oberle, V., Zuhorn, I. S., & Hoekstra, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,872
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,256
Craft, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.233 · Cited by 1,253
Intranasal delivery of biologics to the central nervous system
Lochhead, J. J., & Thorne, R. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.002 · Cited by 1,214
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,139
Research works printed but not linked: 10
- Prados, 2003, A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma, Neuro-Oncology, 5, 96, 10.1093/neuonc/5.2.96 · DOI
- Sanjay, 2011, Der Pharmac. Sin., 2, 94
- Huang, 1996, Microsphere transport pathways in the rabbit nasal mucosa, Int. J. Pharm. Adv., 1, 298
- Aswathy, 2013, Emulsomes: a novel liposoomal formulation for sustained drug delivery, Int. Res. J. Pharm., 3, 192
- Desai, 2012, Evaluation of brain targeting for the nasal delivery of midazolam, Int. J. Pharm. Sci. Rev. Res., 12, 109
- Kanazawa, 2011, Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration, Pharm. Res., 28, 2130, 10.1007/s11095-011-0440-7 · DOI · Paper page
- Patel, 2012, Nanocarriers as novel nose-to-brain targeted drug delivery platforms, Indian J. Nov. Drug Deliv, 4, 243
- Abdelbary, 2013, Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in-vitro characterization, ex-vivo estimation of nasal toxicity and in-vivo biodistribution studies, Int. J. Pharm., 452
- Haruta, 2012, Meeting the needs for nasal delivery devices for powder formulations, Drug Dev. Deliv., 12, 22
- Suman, 1999, Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump, Pharm. Res., 16, 1648, 10.1023/A:1011933410898 · DOI
Cited by
Sorted by citations
Items 301–400 of 403
Verma, P., Khatun, R., Jew, K. A., Prusty, S. K., & Knafo, S. (2025) · Neuropeptides · doi:10.1016/j.npep.2025.102559 · Cited by 3
Nanomaterials in Drug Delivery and Pharmaceutical Applications: A Review
Merzah, Z. F., Abdalameer, N. K., Shanan, Z. J., & Sabah, A. H. (2025) · Nano LIFE · doi:10.1142/s1793984426300013 · Cited by 3
Tiagabine Incorporated Polymeric Microneedles: Formulation and Characterization Studies
Aykaç, K., & Başaran, E. (2023) · Current Applied Polymer Science · doi:10.2174/2452271606666230427091330 · Cited by 3
Mali, A., & Bhanwase, A. S. (2024) · Acta chimica slovenica · doi:10.17344/acsi.2023.8461 · Cited by 3
Nose to brain delivery of drugs for CNS diseases
Ali, Z. H., & Alkotaji, M. M. (2021) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2021.168804 · Cited by 3
Shireesha, J. R., Mutalik, S., Viswanatha, G. L., Kumar, G., John, J., Chamallamudi, M. R., Das, A., DAS, S. K., & Nandakumar, K. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385291482240426101519 · Cited by 3
Xia, X., Zhang, Y., Yang, G., Cao, M., Chen, X., Li, L., Wang, C., & Wu, W. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125185 · Cited by 3
Exosomes: Novel Bio-Inspired Nanocarriers for Efficient Targeting of Glioblastoma Tumor Cells
Nooshabadi, V. T., Arab, S., & Taghdiri-Nooshabadi, Z. (2021) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Hong, S., Lin, C., Hu, J., Piao, J., & Piao, M. G. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00634 · Cited by 2
Kakono, C., Witika, B. A., Makoni, P. A., & Walker, R. B. (2025) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2025.2516237 · Cited by 2
Kong, R., Ma, Q., Zhu, L., Feng, F., Liu, W., & Han, L. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126285 · Cited by 2
Ultrasound-mediated blood-brain barrier opening for targeted neurological drug delivery
Qin, Z., Wang, Z., Gao, C., Yong, X., Hua, Y., Zhou, Y., & Xie, J. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214754 · Cited by 2
Chu, H., Sun, Y., Huang, C., Wang, L., Guo, Q., & Jiang, L. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s564013 · Cited by 2
Mou, Y., Li, Q., Wang, Y., Song, X.-Y., Wang, H., Liu, W.-C., Cheng, Y.-C., Shen, H., Ren, C., & Song, X.-C. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s585021 · Cited by 2
Preparation and Evaluation of Rivastigmine Liposomes for Intranasal Delivery
Yang, Z. (2021) · Biomaterial engineering · doi:10.1007/978-3-662-49320-5_21 · Cited by 2
Nasal Route: A Breakthrough for Drug Delivery
Chattopadhyay, S., Chakraborty, S., Maity, S. C., Sheel, S., Roy, D., Biswas, S., Nag, M., Mandal, S., & Sen, A. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s09.038 · Cited by 2
Stability of Polymeric Micelles and Their Regulatory Status
Thirugnanasambandham, I., Aasaithambi, K., Nizam, I., & Kuppusamy, G. (2023) · Springer eBooks · doi:10.1007/978-981-99-0361-0_15 · Cited by 4
Hafner, A., & Szabó‐Révész, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-20298-8_16 · Cited by 2
Nose-to-Brain Drug Delivery Strategies for the Treatment of Neurological Disorders
Prabakaran, A., Bhatane, D., & Alexander, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_17 · Cited by 2
Refinement of intranasal delivery in rats: A cadaveric study
Nunes-Pereira, M., Venâncio, C. A. S., Pinto, M. D. L., Alves‐Pimenta, S., & Colaço, B. (2024) · Laboratory Animals · doi:10.1177/00236772241241561 · Cited by 3
An Emerging Prospective of Antipsychotics for Treating Neurodegenerative Disorders
Kumar, B., Sahoo, A., Singhal, M., Varshney, G., Halder, T., & Bali, V. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128344910241211112452 · Cited by 2
Intranasal delivery of rotigotine to the brain for treating Parkinson’s disease
Kou, D., Xu, K., Yin, J., Wang, N., Zhang, R., Zeng, J., & Gao, M. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.02.004 · Cited by 2
Wang, P., Zhang, C., Meng, L., Xu, S., Zhang, J., Wang, H., Liang, H., Wang, W., Liu, J., & Zhu, X. (2025) · Small · doi:10.1002/smll.202505141 · Cited by 2
Xylometazoline nasal spray solution: novel composition used for treatment of nasal congestion
Bhuva, F. (2018) · MOJ Drug Design Development & Therapy · doi:10.15406/mojddt.2018.02.00054 · Cited by 2
Cortinhas, J., Pêgo, A. P., & Moreno, P. M. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00009-x · Cited by 2
Glioblastoma Break-in; Try Something New
Bogoyavlenskaya, T. A., Tyagunova, E. E., Kostin, R. K., Захаров, А. С., Vasil’ev, Y. L., & Kytko, O. V. (2021) · International Journal of Cancer Management · doi:10.5812/ijcm.109054 · Cited by 2
Luciani-Giacobbe, L. C., Sanchez, M. F., & Olivera, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-84860-6_102 · Cited by 2
Tesch, M. L., Malakar, A., Rizvi, S. A. A., Akash, M. M. H., Ferrer, G., & Basu, S. (2023) · Preprints.org · doi:10.20944/preprints202312.1002.v1 · Cited by 2
Nanotechnology for Drug Design and Drug Delivery
Weerasinghe, L., Munaweera, I., & Kumarage, S. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238815124010005 · Cited by 1
Presswala, Z., Shah, S., & Aacharya, D. S. P. (2024) · ADMET & DMPK · doi:10.5599/admet.2214 · Cited by 1
Nose-to-brain delivery of nano-engineered biomaterials for effective targeting to the brain
Kashif, M. U. R., Sohail, M. F., Mahmood, A., Shah, S. A., Abbasi, M., & Kousar, M. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2024.2383412 · Cited by 1
Li, J., Tong, S., Yi, H., Liu, R., Hu, W., Tao, S., Huang, H., & Wu, J. (2025) · Journal of Cluster Science · doi:10.1007/s10876-025-02832-z · Cited by 1
Biomaterials Today and Tomorrow
Hamzawy, E. M. A., El-Bassyouni, G. T., Kenawy, S. H., Mabrouk, M., Eldera, S. S., & Omar, A. E. (2025) · Advances in material research and technology · doi:10.1007/978-3-031-97481-6_2 · Cited by 1
Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases
Kalita, R., Sarma, A., Baruah, H., Zaman, A., & Goswami, D. (2026) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.70021 · Cited by 3
Saitani, E.-M., Papakyriakopoulou, P., Damalas, D. Ε., Balafas, E., Kostomitsopoulos, N. G., Pispas, S., Pippa, Ν., Thomaidis, N., & Valsami, G. N. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126855 · Cited by 1
Das, S., Sarkar, M., Bagchi, A., & Bahadur, S. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02054-4 · Cited by 1
Huang, L., Liu, Z., Zhang, Q., Xie, W., Li, G., Yan, J., Qin, M., & Wang, X. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.153517 · Cited by 1
Transnasal nimodipine-loaded mucoadhesive nanoliposomes: Preparation and in-vitro evaluation
Hussein, N., & Omer, H. K. (2019) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2019.027 · Cited by 1
The Strategies of Nanomaterials for Drug Delivery and Release
Wang, J., Huang, Q., & Liang, X. (2019) · Springer eBooks · doi:10.1007/978-981-13-8731-9_3 · Cited by 1
Innovative approach for nasal drug delivery system for brain target
Patil, P. G., Marodkar, S. V., Dighade, S. J., Dongare, P. N., & Borade, B. A. (2021) · GSC Advanced Research and Reviews · doi:10.30574/gscarr.2021.9.3.0296 · Cited by 1
Biological nanodrugs for brain targeting
Jovčevska, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00028-2 · Cited by 1
Nanovesicles for the delivery of cardiovascular drugs
Marson, D., Aulić, S., Fermeglia, A., Laurini, E., & Pricl, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00009-2 · Cited by 1
Supramolecular hydrogels as drug delivery systems for nerve regeneration and wound healing
Sanapala, P., & Pola, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91376-8.00025-2 · Cited by 1
Perspective Chapter: Nose-to-Brain Drug Delivery through Liposomes - Recent Applications
Hafeez, A., & Usmani, S. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106374 · Cited by 1
Abdelkawi, A., Martinez, J. P. P., & Pathak, Y. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_18 · Cited by 1
FORMULATION AND EVALUATION OF PRONIOSOMAL GEL FOR DOXYCYCLINE
Fatma, S., Maurya, M. P., & Mishra, D. J. N. (2023) · doi:10.53555/jptcp.v30i4.2847 · Cited by 1
Targeting angiogenesis, inflammation, and oxidative stress in depression
Akhtar, A., & Dwivedi, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13587-3.00004-7 · Cited by 1
Liposomes for drug delivery to the brain
Agrawal, M., Singh, S., & Alexander, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15491-1.00006-7 · Cited by 1
Polymeric micelles for drug delivery: properties, designs and applications
Raina, N., Singh, M., Rani, R., Garg, A., Sharma, A., Kumar, P., & Gupta, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-819979-4.00006-4 · Cited by 1
Sultana, S., & Devi, A. S. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00295 · Cited by 1
Pereira, K. A. B., Mansur, C. R. E., & Jurgilas, P. B. (2024) · Revista Eletrônica Perspectivas da Ciência e Tecnologia · doi:10.22407/1984-5693.2024.v16.p.20241606
Liposomes as a Potential Carrier for Brain Delivery
Thakur, A. S., Vishwas, S., Badwaik, H., Paul, S. D., Sakure, K., & Nakhate, K. T. (2024) · Springer eBooks · doi:10.1007/978-981-97-2859-6_6 · Cited by 1
Opportunities and Challenges of Biomaterials in Brain Disease
Zheng, W., Jiang, M., Dong, N., Fang, H., Tian, H., & Chen, X. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500746 · Cited by 2
Sultana, A., Shafeeh, A. R., Ahmed, M. G., Biju, P., Sindhu Priya, E. S., & Hussain, M. S. (2025) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073385084250523043452 · Cited by 1
Intranasal Medication Delivery in Children for Brain Disorders
Zhang, G., McCrary, M. R., & Wei, L. (2019) · Springer series in translational stroke research · doi:10.1007/978-3-030-16715-8_11 · Cited by 1
An Alternate View of Neuroprotection with Peptides in Alzheimer’s Disease
King, S. P., & Suphioglu, C. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91065 · Cited by 1
Lavanya, M. N., Preethi, R., Moses, J. A., & Anandharamakrishnan, C. (2021) · Food Reviews International · doi:10.1080/87559129.2021.1888971 · Cited by 1
Langel, Ü. (2019) · Springer eBooks · doi:10.1007/978-981-13-8747-0_5 · Cited by 1
studies, O. T. R. N. C. E. S. C. I. C., device, A. S. P. A. E. I. C. S. U. T. R. P. R. C. D. P. I. (. A. W. A. D. D., sensors, I. I. P. T. U. E. A. V. O. D. T. S. D. T. B. T. C. B. O. B. I. T. T. O. D. W. T. C. S. B. E. T. C. W. A. V. O. C. O. (., data, W. A. A. T. I. S. C. P. B. W. O. L. T., capsule, I. F. T. P. T., profile, I. F., instrumentation, O. O. I. T. A. C. O. S. C. E. T. E. A. T. I., studies, W. T. D. I. D. F. L. I. C., usage, R. A. S. I. I. T. L. O. U. D. C. I. I. A. C. T. T. Q. D. C. P. I. C. O. A., studies, P. I. W. D. O. C. B. D. F. D. E., et al. (2020) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2020.ab01.abstracts · Cited by 1
Luciani-Giacobbe, L. C., Sanchez, M. F., & Olivera, M. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_102-1 · Cited by 1
Preparation and Evaluation of Rivastigmine Liposomes for Intranasal Delivery
Yang, Z. (2018) · Springer Reference Technik · doi:10.1007/978-3-662-49231-4_21-1
New Nonsteroidal Molecules as Blockers of the Steroidogenic Pathway
Cabeza, M., Piermattey, J., Ahumedo, M., Heuze, Y., & Soriano, J. (2022) · Current Enzyme Inhibition · doi:10.2174/1573408018666220106151712
Impaired peri-olfactory cerebrospinal fluid clearance mediated cognitive decline after dyssomniaPreprint
Zhou, Y., Wang, R., Luo, Z., Wang, J., Fang, M., Wei, K., Sun, J., & Lou, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.05.482807
Effect of divalent cations on the uptake of Mn3O4 nanoparticles by olfactory epithelial cells
(2022) · International Multiconference on Bioinformatics of Genome Regulation and Structure / Systems Biology (BGRS/SB) · doi:10.18699/sbb-2022-391
Higashisaka, K. (2023) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.22-00156-3
Plant polysaccharides for nasal drug delivery
Necolau, M. I., Pandele, A. M., & Voicu, Ș. I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90780-4.00008-5
Yallamalli, I. M., Dommaraju, A. K., & YELLAMELLI, R. (2023) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/22.2.156-170
Potential Targeting Sites to the Brain Through Nasal Passage
Govender, M., Indermun, S., Kumar, P., & Choonara, Y. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_6
Desarrollo y evaluación clínica de una formulación intranasal de butorfanol para uso en equinos
Velloso, M. I. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/152394
Sipos, B. (2023) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11595
Langel, Ü. (2023) · Springer eBooks · doi:10.1007/978-3-031-38731-9_9
Essential Considerations for Brain Delivery of Nanoformulations
Chaurasiya, S., & Kulhari, H. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_11
Current common prodrug delivery methods and biochemical property
Zhu, Z. (2024) · Theoretical and Natural Science · doi:10.54254/2753-8818/32/20240798
Recent Advancement in the Use of Medicinal Plants in Brain Aging
Paul, S., Majhi, A., & Sardar, P. S. (2024) · Springer eBooks · doi:10.1007/978-981-99-7269-2_14
Polymeric Nanoparticles for Nose-to-Brain Delivery in Alzheimer’s and Parkinson’s Diseases
Morawski, A. S., Fachel, F. N. S., Pohlmann, A. R., Guterres, S. S., & Frank, L. A. (2024) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-62604-3_7
Safety, Stability Concerns, and Regulatory Aspects of Nanocarriers for Brain Delivery
Jitendra, N. N., Alam, M. I., Mazahir, F., & Yadav, A. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-2859-6_13 · Cited by 1
Advanced drug delivery systems in the management of CNS disorders
Bidaliya, V., Alam, M. R., Bhratee, A., Kumar, M., Anand, P., Chawla, P. A., & Singh, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00020-2
Liquid nano crystals: A new frontier in drug delivery
Sadhana, B. (2024) · i-manager s Journal on Life Sciences · doi:10.26634/jls.3.3.21602
Intranasal drug delivery: reality and prospects
Lavrenova, G. V., & Oganyan, K. A. (2025) · Russian Rhinology · doi:10.17116/rosrino202533021143
Saraiva, N. M., Alves, A. C., Barbosa, A. I., Marinho, A., Reis, S., Correia‐da‐Silva, M., & Costa, P. C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060771
Connecting Link Between Dysbiotic Microbiota and Alzheimer’s Disease: Role of Phytochemicals
Kumari, S., Verma, H., Gangwar, P., Yadav, A., Yadav, B., Rao, R., Mantha, A. K., & Dhiman, M. (2025) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-031-80973-6_20
Nasal In Situ Hydrogels: A Boon For Anti-Emetic Drug Delivery
Boraste, S. V., & Patil, S. K. (2025) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2025053412
Phytopharmaceuticals for Brain Tumor: Opportunities and Challenges
Verma, S., Narayan, C. V., Grewal, A. S., Saini, M., & Chaudhary, G. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898811747125010004
Fouad, G. I., Aly, H. F., & Rizk, M. Z. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-4627-4.ch004
Paruparla, R., Lalan, M. S., Shah, P., & Vasdev, N. (2026) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2026.2614071
HS15-based nanotherapeutics for direct nose-to-brain delivery against central nervous system fungal
Zhang, G., Ji, X., Zhang, W., & Mao, Y. (2026) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2026.104232
Hu, Y., Liu, T., Zhang, Y., Ding, M., Shi, G., Su, H., Guan, J., & Fan, X. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114887
Aldeir, M., & Othman, M. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00181
Multifunctional metal oxide nanoparticles for diverse therapeutic approaches in glioblastoma
Ortiz-Islas, E., Montes, P., Silva‐Adaya, D., Rodríguez-Pérez, C. E., Manríquez-Ramírez, M. E., Cerna-Cortés, J. F., & Campos‐Peña, V. (2026) · Nanotechnology Reviews · doi:10.1515/ntrev-2025-0289
Nose-to-Brain Delivery of Biologicals
Torres, J., Correia, A. C., & Silva, A. C. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_8
Mehrjardi, S. T., Tafaghodi, M., Yari, D., Kamali, H., & Nokhodchi, A. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03430-6
Zhang, Y., Pu, J., Shen, Z., Zhang, Y., Liu, J., Zhang, D., Deng, K., & Yao, Y. (2026) · World Neurosurgery · doi:10.1016/j.wneu.2026.125172
Biopolymer-based Therapeutic Approaches as Effective Treatment Methods for Alzheimer's Disease
Karati, D., & Meur, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010016
Zhu, N., Guo, L., Wang, S., Yao, J., Fang, M., & Ying, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06072-8
Zhang, M., He, W.-Y., Ma, W.-C., & Yu, S.-F. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106983
Modelling Olfactory Dysfunction in Rodents Through Intranasal Vanadium Exposure
Pereira, M., Alves‐Pimenta, S., Venâncio, C. A. S., Pinto, M. D. L., & Colaço, B. (2026) · Animals · doi:10.3390/ani16182877
Metadata
- Authors
- Khan, A. R., Liu, M., Khan, M. W., & Zhai, G.
- Affiliations
- Shandong University (CN)
- Corresponding author
- Zhai, Guangxi
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 268
- Pages
- 364-389
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2750980441
- Cited by
- 402
- References
- 286
- Citations by year
- 2026: 23 · 2025: 54 · 2024: 61 · 2023: 50 · 2022: 60 · 2021: 56 · 2020: 41 · 2019: 36 · 2018: 20 · 2017: 1
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Funders
- China-Australia Centre for Health Sciences Research (2016GJ01)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- intranasal drug delivery, blood-brain barrier, olfactory pathway, trigeminal pathway, nanoparticles, liposomes, polymeric micelles, nasal mucosa, neurotherapeutics, Carbopol 934P, carboxymethyl cellulose, penetratin, PLGA, Tween 80
- MeSH terms
- Administration, Intranasal, Animals, Brain, Humans, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review